Currently, out of the existing stock ratings of Kelly Shi - 7 which are a Buy (87.5%), 1 which are a Hold (12.5%)

Kelly Shi

Work Performance Price Targets & Ratings Chart

Analyst Kelly Shi works at JEFFERIES and is covering the Healthcare sector with 17 price targets and ratings displayed on 4 stocks.

Kelly Shi's average stock forecast success ratio is 41.67% with an average time for price targets to be met of 79.25 days.

Most recent stock forecast was given on MLTX, at 11-Aug-2023.

Wall Street Analyst Kelly Shi

Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for IMGN (IMMUNOGEN) at 11/30/2021. The price target of $7 was fulfilled within 2 days with a profit of $0.83 (13.45%) receiving and performance score of 67.26.

Average potential price target upside

HGEN Humanigen IMGN ImmunoGen KYMR Kymera Therapeutics MLTX

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Sell

0.5

$0.49 (4900.00%)

6

6 months ago

1/4 (25%)

$3.09 (76.73%)

21

Hold

2

8 months 22 days ago

0/2 (0%)

$6.29 (154.45%)

Buy

19

$18.86 (13471.43%)

19

1 years 9 months ago

0/5 (0%)

$14.39 (153.53%)

Sell

21

2 years 24 days ago

2/2 (100%)

$0.83 (4.65%)

18

Buy

30

$29.99 (299900.00%)

30

2 years 1 months 9 days ago

0/2 (0%)

$11.69 (64.34%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Kelly Shi is most bullish on?

Potential upside of $5.42 has been obtained for MLTX

What Year was the first public recommendation made by Kelly Shi?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart